Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 19.89
+0.06 (0.30%)
At close: Jul 29, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 10.11 billion as of July 29, 2026. Its market cap has decreased by -36.79% in one year.
Market Cap
10.11B
Enterprise Value
9.96B
Revenue
679.75M
Ranking
n/a
PE Ratio
393.79
Stock Price
19.89
ChartMarket Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 10.11B, an increase of 22.39%. That is a compound annual growth rate of 4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 10.11B | -17.67% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shyndec Pharmaceutical | 11.36B |
| Zhejiang Medicine | 11.29B |
| Zhejiang CONBA Pharmaceutical | 10.96B |
| Zhejiang Jingxin Pharmaceutical | 10.95B |
| Yantai Dongcheng Pharmaceutical Group | 10.22B |
| Mayinglong Pharmaceutical Group | 9.98B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 9.82B |
| Ningbo Menovo Pharmaceutical | 9.42B |